Geode Capital Management LLC Acquires 84,889 Shares of agilon health, inc. (NYSE:AGL)

Geode Capital Management LLC grew its holdings in shares of agilon health, inc. (NYSE:AGL) by 1.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,893,517 shares of the company’s stock after purchasing an additional 84,889 shares during the quarter. Geode Capital Management LLC owned approximately 1.67% of agilon health worth $27,097,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Barclays PLC boosted its stake in agilon health by 21.2% in the third quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock valued at $4,830,000 after acquiring an additional 214,830 shares during the last quarter. XTX Topco Ltd lifted its position in shares of agilon health by 271.1% during the 3rd quarter. XTX Topco Ltd now owns 119,747 shares of the company’s stock valued at $471,000 after buying an additional 87,481 shares during the last quarter. State Street Corp grew its stake in shares of agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after acquiring an additional 215,733 shares during the period. Quadrature Capital Ltd purchased a new stake in agilon health in the 3rd quarter worth about $261,000. Finally, Point72 DIFC Ltd bought a new stake in agilon health in the 3rd quarter valued at about $99,000.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on AGL. Macquarie assumed coverage on shares of agilon health in a research note on Monday, December 16th. They issued a “neutral” rating and a $3.00 target price for the company. Bank of America lowered shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a research note on Wednesday, October 2nd. William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Stifel Nicolaus decreased their price objective on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research note on Tuesday, November 12th. Finally, JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Three analysts have rated the stock with a sell rating, sixteen have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $4.28.

agilon health Trading Down 1.0 %

Shares of AGL stock opened at $1.89 on Friday. The business has a 50-day moving average price of $2.20 and a two-hundred day moving average price of $4.12. agilon health, inc. has a 12-month low of $1.50 and a 12-month high of $13.28. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a market cap of $778.71 million, a P/E ratio of -2.01 and a beta of 0.51.

agilon health (NYSE:AGL) last released its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same quarter in the previous year, the firm earned ($0.06) EPS. Equities analysts anticipate that agilon health, inc. will post -0.52 EPS for the current fiscal year.

Insider Activity

In related news, Director Diana Mckenzie bought 12,500 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The stock was bought at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the acquisition, the director now directly owns 51,319 shares of the company’s stock, valued at $117,007.32. The trade was a 32.20 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Karen Mcloughlin purchased 25,000 shares of the firm’s stock in a transaction on Friday, December 13th. The stock was bought at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the purchase, the director now directly owns 73,166 shares in the company, valued at approximately $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 90,000 shares of company stock valued at $198,100. Corporate insiders own 3.20% of the company’s stock.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.